Skip to content
Search

Latest Stories

Almost 300,000 accessed NHS online tool to check Type 2 diabetes risk

Amid rising number of Covid-19 cases, almost 300,000 people have accessed the online tool to check their risk of Type 2 diabetes, the National Health Service (NHS) has said.

The number of people who use the online tool climbed in less than two months after the NHS fast tracked access to its ‘Healthier You Diabetes Prevention Programme’.


Access to the programme was boosted following new findings that people are twice as likely to die from Covid-19 if they have Type 2 diabetes.

“Latest figures show that 291,325 people used the ‘Diabetes UK Know Your Risk’ tool since the end of July – a 637 per cent increase compared to two months previously,” it said

Over 5,000 people have now self-referred for support to lose weight and prevent the onset of Type 2 diabetes and the programme has capacity to support 5,000 people every week.

The NHS is now urging even more people who are at risk to check their risk and sign up.

People can use the online test, hosted by Diabetes UK, to calculate their risk of developing the condition by answering basic questions including age, weight and ethnicity.

If their score comes back as sufficiently high, they can refer themselves to a local service for support remotely or online, without having to go through a healthcare professional.

Professor Jonathan Valabhji, NHS national clinical director for diabetes and obesity said: “The fact that two thirds of our nation live with being overweight or obese coupled with the increased risk of more severe outcomes from coronavirus means that there has never been a better time to lose weight, exercise more and eat more healthily.

“It’s great to see so many people becoming more aware of their personal risk level, but we want to see even more people signing up to the support we have available. It is free and could be life-changing.”

“As the first national initiative of its kind in the world, over half a million people have been referred and those with overweight or obesity completing the programme lost on average 3.6kg, in line with the studies that demonstrated reduced onset of Type 2 diabetes,” the NHS has noted.

Those who qualify will be able to choose how they complete the programme, either by joining group sessions by video link or telephone with an experienced coach or through digital support, which includes online peer support groups and in some areas, wearable tech.

Previously, people had to go to their GP or visit a healthcare professional and get a blood test before a referral, but the risk of coronavirus has meant that less people have had face-to-face GP appointments and less people are accessing blood tests.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less